Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes.

L. Hanafi,Marilène Bolduc,M. L. Gagné,F. Dufour,Y. Langelier,M. Boulassel,J. Routy,D. Leclerc,R. Lapointe
DOI: https://doi.org/10.1016/j.vaccine.2010.06.024
IF: 4.169
2010-08-02
Vaccine
Abstract:
What problem does this paper attempt to address?